26 related articles for article (PubMed ID: 35511742)
1. Prostate cancer diagnosis rates among insured men with and without HIV in South Africa: a cohort study.
Ruffieux Y; Fernandez Villalobos NV; Didden C; Haas AD; Chinogurei C; Cornell M; Egger M; Maartens G; Folb N; Rohner E
Cancer Epidemiol Biomarkers Prev; 2024 May; ():. PubMed ID: 38713162
[TBL] [Abstract][Full Text] [Related]
2. Design and Implementation of Taizhou Integrated Prostate Screening.
Li FP; Zhang MX; Wang LJ; Zhu XL; Sun LX; Chen ZX; Chen WY; Liu DY; Li HP; Jiang YY; Tung TH
Am J Mens Health; 2022; 16(6):15579883221138192. PubMed ID: 36412060
[TBL] [Abstract][Full Text] [Related]
3. Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study.
Stikbakke E; Schirmer H; Knutsen T; Støyten M; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Richardsen E; Thune I
Cancer Med; 2022 Feb; 11(4):1005-1015. PubMed ID: 34939344
[TBL] [Abstract][Full Text] [Related]
4. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study.
Jochems SHJ; Fritz J; Häggström C; Järvholm B; Stattin P; Stocks T
Eur Urol; 2023 May; 83(5):422-431. PubMed ID: 35523620
[TBL] [Abstract][Full Text] [Related]
5. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
6. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
Sarkar RR; Parsons JK; Bryant AK; Ryan ST; Kader AK; McKay RR; D'Amico AV; Nguyen PL; Hulley BJ; Einck JP; Mundt AJ; Kane CJ; Murphy JD; Rose BS
JAMA Intern Med; 2019 Jun; 179(6):812-819. PubMed ID: 31058923
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure and risk of prostate cancer: Cohort Norway (CONOR).
Martin RM; Vatten L; Gunnell D; Romundstad P
Cancer Causes Control; 2010 Mar; 21(3):463-72. PubMed ID: 19949849
[TBL] [Abstract][Full Text] [Related]
8. Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study.
Jochems SHJ; Häggström C; Stattin P; Järvholm B; Stocks T
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1483-1491. PubMed ID: 35511742
[TBL] [Abstract][Full Text] [Related]
9. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
[TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
11. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
Nair B; Wilt T; MacDonald R; Rutks I
Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
